These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9590083)

  • 1. [Carnitine/acylcarnitine translocase deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):403-4. PubMed ID: 9590083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carnitine acylcarnitine translocase deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):57-9. PubMed ID: 11596450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carnitine transporter defect].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):398-400. PubMed ID: 9590081
    [No Abstract]   [Full Text] [Related]  

  • 4. Carnitine-acylcarnitine translocase deficiency: phenotype, residual enzyme activity and outcome.
    Lopriore E; Gemke RJ; Verhoeven NM; Jakobs C; Wanders RJ; Roeleveld-Versteeg AB; Poll-The BT
    Eur J Pediatr; 2001 Feb; 160(2):101-4. PubMed ID: 11271379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase.
    Ogier de Baulny H; Slama A; Touati G; Turnbull DM; Pourfarzam M; Brivet M
    J Pediatr; 1995 Nov; 127(5):723-8. PubMed ID: 7472823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carnitine acylcarnitine translocase deficiency].
    Kimura M; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():714-6. PubMed ID: 12013981
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of four carnitine-acylcarnitine translocase deficiency cases caused by homozygous mutation of SLC25A20 c.199-10T> G].
    Fan X; Xie BB; Zhang Q; Yi S; Geng GX; Yang Q; Luo JS; Wang J; Li C; Chen SK; Shen YP
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):545-549. PubMed ID: 29996190
    [No Abstract]   [Full Text] [Related]  

  • 8. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 9. Carnitine-acylcarnitine translocase deficiency: implications in human pathology.
    Pande SV; Murthy MS
    Biochim Biophys Acta; 1994 Jul; 1226(3):269-76. PubMed ID: 8054358
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
    Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
    Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
    Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
    Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency.
    Ogawa A; Yamamoto S; Kanazawa M; Takayanagi M; Hasegawa S; Kohno Y
    J Hum Genet; 2000; 45(1):52-5. PubMed ID: 10697964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitochondrial carnitine acylcarnitine translocase].
    Kimura M; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():85-7. PubMed ID: 12014004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carnitine palmitoyltransferase I(CPT1) deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):401-2. PubMed ID: 9590082
    [No Abstract]   [Full Text] [Related]  

  • 15. Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals.
    Fukushima T; Kaneoka H; Yasuno T; Sasaguri Y; Tokuyasu T; Tokoro K; Fukao T; Saito T
    J Hum Genet; 2013 Dec; 58(12):788-93. PubMed ID: 24088670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency.
    Niezen-Koning KE; van Spronsen FJ; Ijlst L; Wanders RJ; Brivet M; Duran M; Reijngoud DJ; Heymans HS; Smit GP
    J Inherit Metab Dis; 1995; 18(2):230-2. PubMed ID: 7564255
    [No Abstract]   [Full Text] [Related]  

  • 17. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.
    Rubio-Gozalbo ME; Vos P; Forget PP; Van Der Meer SB; Wanders RJ; Waterham HR; Bakker JA
    Acta Paediatr; 2003 Apr; 92(4):501-4. PubMed ID: 12801121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
    Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
    Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial neonatal SIDS revealing carnitine-acylcarnitine translocase deficiency.
    Nuoffer JM; de Lonlay P; Costa C; Roe CR; Chamoles N; Brivet M; Saudubray JM
    Eur J Pediatr; 2000; 159(1-2):82-5. PubMed ID: 10653336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.